Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$14.59 - $20.0 $639,042 - $876,000
43,800 Added 104.78%
85,600 $1.65 Million
Q2 2024

Aug 15, 2024

BUY
$13.6 - $17.06 $428,400 - $537,390
31,500 Added 305.83%
41,800 $606,000
Q1 2024

May 07, 2024

SELL
$13.68 - $17.6 $161,424 - $207,680
-11,800 Reduced 53.39%
10,300 $178,000
Q4 2023

Feb 14, 2024

SELL
$14.87 - $17.56 $965,063 - $1.14 Million
-64,900 Reduced 74.6%
22,100 $377,000
Q3 2023

Nov 14, 2023

SELL
$16.8 - $20.99 $2.61 Million - $3.26 Million
-155,400 Reduced 64.11%
87,000 $1.47 Million
Q2 2023

Aug 11, 2023

BUY
$16.03 - $20.07 $2.74 Million - $3.43 Million
171,100 Added 239.97%
242,400 $4.86 Million
Q1 2023

May 16, 2023

BUY
$15.67 - $18.91 $1.12 Million - $1.35 Million
71,300 New
71,300 $1.24 Million
Q3 2022

Nov 14, 2022

BUY
$14.23 - $17.76 $220,565 - $275,280
15,500 New
15,500 $238,000

Others Institutions Holding BLCO

About Bausch & Lomb Corp


  • Ticker BLCO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 350,000,000
  • Market Cap $6.89B
  • Description
  • Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...
More about BLCO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.